Evidence map›Paper›PMID 36460776›Full record

ArticleBritish journal of cancer2023

Body shape phenotypes of multiple anthropometric traits and cancer risk: a multi-national cohort study.

Anja M Sedlmeier, Vivian Viallon, Pietro Ferrari, Laia Peruchet-Noray, Emma Fontvieille, Amina Amadou, Nazlisadat Seyed Khoei, Andrea Weber, Hansjörg Baurecht, Alicia K Heath and 22 more

Open access · hybridAbstract read
In one paragraph

Article in British journal of cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 20 institutions in 9 countries.

Anja M SedlmeierDepartment of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany.
Vivian ViallonInternational Agency for Research on Cancer (IARC), Nutrition and Metabolism Branch, Lyon, France.
Pietro FerrariInternational Agency for Research on Cancer (IARC), Nutrition and Metabolism Branch, Lyon, France.ORCID http://orcid.org/0000-0001-9358-7338
Laia Peruchet-NorayInternational Agency for Research on Cancer (IARC), Nutrition and Metabolism Branch, Lyon, France.
Emma FontvieilleInternational Agency for Research on Cancer (IARC), Nutrition and Metabolism Branch, Lyon, France.
Amina AmadouDepartment of Prevention Cancer Environment, Centre Léon Bérard, Lyon, France.
Nazlisadat Seyed KhoeiDepartment of Nutritional Sciences, Faculty of Life Sciences, University of Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0001-6003-7794
Andrea WeberDepartment of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany.
Hansjörg BaurechtDepartment of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany.
Alicia K HeathDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.ORCID http://orcid.org/0000-0001-6517-1300
Kostas TsilidisDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.ORCID http://orcid.org/0000-0002-8452-8472
Rudolf KaaksDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID http://orcid.org/0000-0003-3751-3929
Verena KatzkeDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Elif Inan-ErogluDepartment of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
Matthias B SchulzeDepartment of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
Kim OvervadDepartment of Public Health, Aarhus University, Aarhus, Denmark.
Catalina BonetUnit of Nutrition and Cancer, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain.
Esther Ubago-GuisadoEscuela Andaluza de Salud Pública (EASP), Granada, Spain.
María-Dolores ChirlaqueCIBER Epidemiology and Public Health CIBERESP, Madrid, Spain.
Eva ArdanazCIBER Epidemiology and Public Health CIBERESP, Madrid, Spain.
Aurora Perez-CornagoCancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-5652-356X
Valeria PalaEpidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.ORCID http://orcid.org/0000-0001-5438-970X
Rosario TuminoHyblean Association for Epidemiological Research, AIRE - ONLUS, Ragusa, Italy.ORCID http://orcid.org/0000-0003-2666-414X
Carlotta SacerdoteUnit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital, Turin, Italy.
Fabrizio PasanisiClinical Nutrition Unit, Department of Clinical Medicine and Surgery, Federico II University Hospital, Naples, Italy.
Kristin B BorchDepartment of Community Medicine, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway.ORCID http://orcid.org/0000-0002-1741-2322
Charlotta RylanderDepartment of Community Medicine, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway.
Elisabete WeiderpassInternational Agency for Research on Cancer (IARC), Nutrition and Metabolism Branch, Lyon, France.ORCID http://orcid.org/0000-0003-2237-0128
Marc J GunterInternational Agency for Research on Cancer (IARC), Nutrition and Metabolism Branch, Lyon, France.
Béatrice FerversDepartment of Prevention Cancer Environment, Centre Léon Bérard, Lyon, France.
Michael F LeitzmannDepartment of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany.
Heinz FreislingInternational Agency for Research on Cancer (IARC), Nutrition and Metabolism Branch, Lyon, France. freislingh@iarc.fr.ORCID http://orcid.org/0000-0001-8648-4998
Centre international de recherche sur le cancer · FRUniversity of Regensburg · DEGerman Cancer Research Center · DEInserm · FRUiT The Arctic University of Norway · NOAarhus University · DKAzienda Ospedaliera Citta' della Salute e della Scienza di Torino · ITBellvitge University Hospital · ESFederico II University Hospital · ITFondazione IRCCS Istituto Nazionale dei Tumori · ITGerman Institute of Human Nutrition · DEImperial College London · GBInstituto de Investigación Biosanitaria de Granada · ESInstituto Murciano de Investigación Biosanitaria · ESItalian Association for Cancer Research · ITNavarre Institute of Health Research · ESUniversity of Ioannina · GRUniversity of Oxford · GBUniversity of Potsdam · DEUniversity of Vienna · AT

Funding

Cancer Research UK 14136Cancer Research UK 29017Cancer Research UK C8221/A29017Medical Research Council 1000143Medical Research Council G0401527Medical Research Council G1000143Medical Research Council MR/M012190/1Medical Research Council MR/N003284/1World Health Organization 001
6 · The paper itself

Abstract

backgroundClassical anthropometric traits may fail to fully represent the relationship of weight, adiposity, and height with cancer risk. We investigated the associations of body shape phenotypes with the risk of overall and site-specific cancers.

methodsWe derived four distinct body shape phenotypes from principal component (PC) analysis on height, weight, body mass index (BMI), waist (WC) and hip circumferences (HC), and waist-to-hip ratio (WHR). The study included 340,152 men and women from 9 European countries, aged mostly 35-65 years at recruitment (1990-2000) in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Cox proportional hazards regression was used to estimate multivariable-adjusted hazard ratios (HRs) and 95% confidence intervals (CIs).

resultsAfter a median follow-up of 15.3 years, 47,110 incident cancer cases were recorded. PC1 (overall adiposity) was positively associated with the risk of overall cancer, with a HR per 1 standard deviation (SD) increment equal to 1.07 (95% confidence interval 1.05 to 1.08). Positive associations were observed with 10 cancer types, with HRs (per 1 SD) ranging from 1.36 (1.30-1.42) for endometrial cancer to 1.08 (1.03-1.13) for rectal cancer. PC2 (tall stature with low WHR) was positively associated with the risk of overall cancer (1.03; 1.02-1.04) and five cancer types which were not associated with PC1. PC3 (tall stature with high WHR) was positively associated with the risk of overall cancer (1.04; 1.03-1.05) and 12 cancer types. PC4 (high BMI and weight with low WC and HC) was not associated with overall risk of cancer (1.00; 0.99-1.01).

conclusionsIn this multi-national study, distinct body shape phenotypes were positively associated with the incidence of 17 different cancers and overall cancer.

Indexed as

Rectal NeoplasmsSomatotypesAdiposityBody Mass IndexCohort StudiesFemaleHumansObesityPhenotypeProportional Hazards ModelsProspective StudiesRisk FactorsWaist CircumferenceWaist-Hip Ratio

Identifiers

PMID36460776
PMCPMC9938222
OpenAlexW4310578983

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.